Our ordinary shares are listed for trading in the form of registered ASML NASDAQ shares and in the form of registered ASML Euronext Amsterdam shares. The principal trading market of our ordinary shares is Euronext Amsterdam. Our ordinary shares also trade on NASDAQ.
|Ticker||ISIN / CUSIP||Currency|
|纳斯达克||ASML||N07059210 / USN070592100||US Dollar|
ASML's authorized share capital consists of ordinary shares and cumulative preference shares.
ASML Ordinary Shares
Outstanding per 31 December 2020: 416,514,034 ordinary shares with nominal value EUR 0.09.
Listed at both Euronext Amsterdam and Nasdaq in New York.
699,999,000 shares with nominal value EUR 0.09
ASML Cumulative Preference Shares
Are not issued.
700,000,000 shares with nominal value EUR 0.09
Read more about Cumulative Preference Shares
Cumulative Preference Shares
The nominal value of the cumulative preference shares amounts to EUR 0.09 and the number of cumulative preference shares included in the authorized share capital is 700,000,000. A cumulative preference share entitles the holder thereof to cast nine votes in the General Meeting of Shareholders.
基金会的目标是照顾the interests of ASML and of the enterprises maintained by ASML and of the companies which are affiliated in a group with ASML, in such a way that the interests of ASML, of those enterprises and of all parties concerned are safeguarded in the best possible way, and influences in conflict with these interests which might affect the independence or the identity of ASML and those companies are deterred to the best of the Foundation’s ability, and everything related to the above or possibly conducive thereto. The Foundation seeks to realize its objects by the acquiring and holding of cumulative preference shares in the capital of ASML and by exercising the rights attached to these shares, particularly the voting rights attached to these shares.
Cancellation and repayment of the issued cumulative preference shares by ASML requires the authorization by the General Meeting of Shareholders of a proposal to do so by the BoM approved by the Supervisory Board. If the Preference Share Option is exercised and as a result cumulative preference shares are issued, ASML, at the request of the Foundation, will initiate the repurchase or cancellation of all cumulative preference shares held by the Foundation. In that case ASML is obliged to effect the repurchase and cancellation respectively as soon as possible. A cancellation will have as a result a repayment of the amount paid and exemption from the obligation to pay up on the cumulative preference shares. A repurchase of the cumulative preference shares can only take place when such shares are fully paid up.
基础与ASML无关。该基金会董事会包括荷兰商业和学术界的四名独立成员。基金会董事会成员是：H. Bodt先生M.W. Den Boogert先生，J.M. de Jong先生和A.H.L.L.L.L. ledqvist先生。
The table below reflects information about our major shareholders, based on public filings with the SEC and AFM as of January 31, 2021.
|Capital Research and Management Company||
|Baillie Gifford & Co||
* As a percentage of the total number of ordinary shares issued and outstanding (416,514,034) as of December 31, 2020, which excludes 2,983,454 ordinary shares which have been issued but are held in treasury by ASML. Please note that share ownership percentages reported to the AFM are expressed as a percentage of the total number of ordinary shares issued (including treasury stock) and that accordingly, percentages reflected in this table may differ from percentages reported to the AFM.
Read about US Form 8937 in relation to Cymer shares
US reporting rules under section 6045B of the Internal Revenue Code require an issuer - ASML Holding N.V. - to file an information return (Form 8937) with the Internal Revenue Service whenever the issuer engages in a corporate action that affects the tax basis of a “specified security.” In addition, an issuer - ASML Holding N.V. - is required to furnish to its security holders a written statement containing the same information or to post such statement in a readily accessible format on its primary website. ASML Holding N.V. has decided to post the required information on its primary website. If you have any further questions with regard to the attached form, please contact the Investor Relations department, at +31 (0)40 268 3938.
Synthetic Share Buyback